Stocks in Action: Stellantis, Renk, Safran, Aurubis, Schott Pharma
Reading Time: 5 minutes
Stock 1.) Stellantis - Possible loosening of the internal combustion engine ban in the EU and lower US emission standards provide momentum - DZ Bank upgrades from Sell to Buy and revises fair value up from €7.5 to €13.5! One of the most significant buy ratings comes on Friday from DZ Bank for Stellantis. The automaker (Peugeot, Fiat, Chrysler, Jeep, and Opel) has recently come under considerable pressure due to weak sales development in many core markets and plans to counteract this with multi-billion euro investments of around €13 billion...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

